#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14872	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2458	744.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1909	1909	T	967	T,G,C	962,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14872	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2458	744.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1643	1643	C	927	C	926	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4174	746.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	2004	2004	A	966	A,C	963,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4174	746.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2638	2638	C	885	C,T,G,A	879,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4174	746.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2712	2712	A	802	A,G	801,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4174	746.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3264	3264	C	949	C,G	947,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	G5V	NONSYN	13	15	GGT	664	666	GTT	138;138;138	G;T;T	138;138;138	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	E12K	NONSYN	34	36	GAA	685	687	AAA	157;157;157	A;A,G,C;A	157;155,1,1;157	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	F31L	NONSYN	91	93	TTT	742	744	TTG	165;165;166	T;T;G	165;165;166	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	775	777	CAA	185;187;185	C;A,G,C;A	185;185,1,1;185	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	S75P	NONSYN	223	225	TCC	874	876	CCT	185;184;184	C,A;C;T	183,2;184;184	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	V87A	NONSYN	259	261	GTA	910	912	GCA	167;166;165	G;C,G;A	167;165,1;165	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	V130L	NONSYN	388	390	GTC	1039	1041	CTC	203;205;204	C;T;C	203;205;204	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	R135C	NONSYN	403	405	CGC	1054	1056	TGT	211;212;212	T,C;G;T	210,1;212;212	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	T137A	NONSYN	409	411	ACG	1060	1062	GCG	212;213;211	G;C,A;G,T	212;212,1;209,2	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1102	1104	AAG	213;214;214	A;A;G	213;213;213	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1105	1107	AAT	212;214;213	A,G;A,G;T,A	210,1;212,1;211,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1303	1305	TTG	136;134;134	T;T;G	136;134;134	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1333	1335	AGC	120;121;120	A;G;C,T	120;121;119,1	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1402	1404	CTG	117;117;118	C;T,G;G	117;116,1;118	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1408	1410	TCC	114;115;111	T,A;C;C	113,1;115;111	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1423	1425	GTG	121;122;124	G;T;G	121;122;124	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1672	folP	852	852	93.78	folP.l15.c4.ctg.1	2143	97.3	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1474	1476	GCG	164;162;162	G;C;G	164;162;162	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5254	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3870	169.0	1	SNP	p	S91F	0	.	.	271	273	TCC	818	820	TCC	209;207;203	T,A;C;C,A	208,1;207;202,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5254	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3870	169.0	1	SNP	p	D95G	0	.	.	283	285	GAC	830	832	GAC	208;210;214	G;A;C	208;210;214	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5254	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3870	169.0	1	SNP	p	D95N	0	.	.	283	285	GAC	830	832	GAC	208;210;214	G;A;C	208;210;214	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1346	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1825	92.0	0	.	p	.	0	G27E	NONSYN	79	81	GGG	659	661	GAG	190;189;188	G;A,C;G	189;187,2;188	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1346	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1825	92.0	0	.	p	.	0	D79N	NONSYN	235	237	GAT	815	817	AAT	166;166;164	A;A,G;T,C	166;165,1;163,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1346	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1825	92.0	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	893	895	CAC	197;197;198	C;A;C	197;197;198	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1346	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1825	92.0	0	.	p	.	0	N110S	NONSYN	328	330	AAC	908	910	AGC	197;194;192	A;G;C	197;194;192	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1346	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1825	92.0	0	.	p	.	0	F178L	NONSYN	532	534	TTC	1112	1114	CTC	127;123;122	C;T;C	127;123;122	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1346	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1825	92.0	0	.	p	.	0	S183N	NONSYN	547	549	AGT	1127	1129	AAT	127;129;129	A;A;T	127;129;129	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1346	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1825	92.0	0	.	p	.	0	N203S	NONSYN	607	609	AAC	1187	1189	AGC	148;148;144	A;G;C	148;148;144	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1346	mtrR	633	633	97.47	mtrR.l15.c4.ctg.1	1825	92.0	1	SNP	p	G45D	0	.	.	133	135	GGC	713	715	GGC	177;176;174	G,A;G;C,T,A	175,1;175;172,1,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4992	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3539	176.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1916	1918	GCA	239;237;242	G,A;C;A	237,2;237;242	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4992	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3539	176.0	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2399	2401	ATT	238;237;237	A;T,C;T,G	238;236,1;236,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4992	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3539	176.0	1	SNP	p	D86N	0	.	.	256	258	GAC	869	871	GAC	212;213;213	G;A;C,G	212;213;212,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4992	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3539	176.0	1	SNP	p	S87R	0	.	.	259	261	AGT	872	874	AGT	213;213;213	A;G;T,A	213;213;212,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4992	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3539	176.0	1	SNP	p	S87W	0	.	.	259	261	AGT	872	874	AGT	213;213;213	A;G;T,A	213;213;212,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4992	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3539	176.0	1	SNP	p	S87I	0	.	.	259	261	AGT	872	874	AGT	213;213;213	A;G;T,A	213;213;212,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4992	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3539	176.0	1	SNP	p	S88P	0	.	.	262	264	TCC	875	877	TCC	213;211;211	T;C;C	213;211;211	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4388	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3172	172.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1887	1889	GGC	237;237;233	G,C;G,T;C	236,1;236,1;233	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1493	1495	GCA	260;256;255	G;C;A	260;256;255	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1496	1498	ATC	255;255;255	A;T,C;C	255;254,1;255	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1508	1510	GTG	255;257;257	G;T,G;G	255;256,1;257	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1508	1510	GTG	255;257;257	G;T,G;G	255;256,1;257	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2012	2014	ACC	267;267;266	A;C;C	267;267;266	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2066	2068	GCG	243;239;236	G;C,T,G;G,T	243;237,1,1;235,1	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2066	2068	GCG	243;239;236	G;C,T,G;G,T	243;237,1,1;235,1	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2189	2191	GGT	221;219;221	G,A;G;T,C	220,1;219;220,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2198	2200	GGC	219;222;223	G,T,C;G;C	217,1,1;222;223	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4090	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2954	172.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2216	2218	CCG	225;224;225	C,T;C,T,A;G	224,1;221,2,1;225	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5810	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3575	202.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2274	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2274	124.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	614	616	GGC	164;165;166	G;G;C	164;165;166	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2274	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2274	124.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	796	796	C	163	C	163	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	29;31;32	T;T;A	29;31;32	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	64;64;64	C;A;T	64;64;64	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	64;64;64	A;G;T	64;64;64	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	64;64;64	T,G;A;C	63,1;64;64	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	3;3;3	G;A;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	308	porB1a	984	226	90.71	porB1a.l15.c30.ctg.1	390	32.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3068	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1659	228.9	0	.	p	.	0	E41K	NONSYN	121	123	GAA	563	565	AAA	247;248;244	A;A,C;A,C	247;246,2;243,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3068	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1659	228.9	0	.	p	.	0	I209N	NONSYN	625	627	ATC	1067	1069	AAC	264;267;268	A;A,T,G;C	262;262,2,1;268	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3068	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1659	228.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1073	1073	T	272	T,G	269,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3068	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1659	228.9	1	SNP	p	G120K	0	.	.	358	360	GGT	800	802	GGT	277;276;280	G,C;G,A;T	276,1;275,1;280	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3068	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1659	228.9	1	SNP	p	A121D	0	.	.	361	363	GCC	803	805	GCC	276;277;280	G,C;C,T,G;C,G,A	275,1;275,1,1;278,1,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3068	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1659	228.9	1	SNP	p	A121N	0	.	.	361	363	GCC	803	805	GCC	276;277;280	G,C;C,T,G;C,G,A	275,1;275,1,1;278,1,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10284	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5439	235.7	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2323	2325	CAT	270;268;267	C;A,T;T,A	270;267,1;266,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1492	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1362	136.0	1	SNP	p	V57M	1	.	.	169	171	ATG	718	720	ATG	267;269;270	A;T;G	267;269;270	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
